The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With Hysterectomy
Abstract
CONTEXT: The Women's Health Initiative Estrogen-Aone trial comparing conjugated equine estrogens (CEE) with placebo was stopped early because of an increased stroke incidence and no reduction in risk of coronary heart disease. Preliminary results suggesting possible reduction in breast cancers warranted more detailed analysis. OBJECTIVE: To determine the effects of CEE on breast cancers and mammographic findings. DESIGN, SETTING, AND PARTICIPANTS: Following breast cancer risk assessment, 10,739 postmenopausal women aged 50 to 79 years with prior hysterectomy were randomized to CEE or placebo at 40 US clinical centers from 1993 through 1998. Mammography screenings and clinical breast examinations were performed at baseline and annually. All breast cancers diagnosed through February 29, 2004, are included. INTERVENTION: A dose of 0.625 mg/d of CEE or an identical-appearing placebo. MAIN OUTCOME MEASURES: Breast cancer incidence, tumor characteristics, and mammogram findings. RESULTS: After a mean (SD) follow-up of 7.1 (1.6) years, the invasive breast cancer hazard ratio (HR) for women assigned to CEE vs placebo was 0.80 (95% confidence interval [CI], 0.62-1.04; P = .09) with annualized rates of 0.28% (104 cases in the CEE group) and 0.34% (133 cases in the placebo group). In exploratory analyses, ductal carcinomas (HR, 0.71; 95% CI, 0.52-0.99) were reduced in the CEE group vs placebo group; however, the test for interaction by tumor type was not significant (P = .054). At 1 year, 9.2% of women in the CEE group had mammograms with abnormalities requiring follow-up vs 5.5% in the placebo group (P<.001), a pattern that continued through the trial to reach a cumulative percentage of 36.2% vs 28.1%, respectively (P<.001); however, this difference was primarily in assessments requiring short interval follow-up. CONCLUSIONS: Treatment with CEE alone for 7.1 years does not increase breast cancer incidence in postmenopausal women with prior hysterectomy. However, treatment with CEE increases the frequency of mammography screening requiring short interval follow-up. Initiation of CEE should be based on consideration of the individual woman's potential risks and benefits. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00000611.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Self-citationEstrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,862
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,439
Berg, W. A., Campassi, C., Langenberg, P., & Sexton, M. J. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741769 · Cited by 1,273
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
Ross, R. K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.328 · Cited by 877
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
Steinberg, K. K. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460150089030 · Cited by 626
Morimoto, L. M., White, E., Chen, Z., Chlebowski, R. T., Hays, J., Kuller, L., Lopez, A. M., Manson, J., Margolis, K. L., Muti, P. C., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1020239211145 · Cited by 569
Self-citationPsychological and Behavioral Implications of Abnormal Mammograms
Lerman, C., Track, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-657 · Cited by 481
Li, C. I. (2003) · JAMA · doi:10.1001/jama.289.24.3254 · Cited by 417
Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal Density
Greendale, G. A., Reboussin, B. A., Sie, A., Singh, H. R., Olson, L. K., Gatewood, O., Bassett, L. W., Wasilauskas, C., Bush, T., Barrett-Connor, E., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4_part_1-199902160-00003 · Cited by 401
Ingle, J. N., Ahmann, D. L., Green, S. J., Edmonson, J. H., Bisel, H. F., Kvols, L. K., Nichols, W. C., Creagan, E. T., Hahn, R. G., Rubin, J., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040104 · Cited by 336
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy
Patterson, L. (2004) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/0000000042177072 · Cited by 331
Song, R. X.-D., Mor, G., Naftolin, F., McPherson, R. A., Song, J., Zhang, Z., Yue, W., Wang, J., & Santen, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1714 · Cited by 293
Age-dependent growth rate of primary breast cancer
Peer, P. G. M., van Dijck, J. A. A. M., Verbeek, A. L. M., Hendriks, J. H. C. L., & Holland, R. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3547::aid-cncr2820711114>3.0.co;2-c · Cited by 263
McTiernan, A., Martin, C. F., Peck, J. D., Aragaki, A. K., Chlebowski, R. T., Pisano, E. D., Wang, C. Y., Brunner, R. L., Johnson, K. C., Manson, J. E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji279 · Cited by 254
Self-citationLewis, J. S., Meeke, K., Osipo, C., Ross, E. A., Kidawi, N., Li, T., Bell, E., Chandel, N. S., & Jordan, V. C. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji400 · Cited by 244
Stefanick, M. L., Cochrane, B. B., Hsia, J., Barad, D. H., Liu, J. H., & Johnson, S. R. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00045-0 · Cited by 232
Self-citationLønning, P. E., Taylor, P. D., Anker, G., Iddon, J., Wie, L., Jørgensen, L.-M., Mella, O., & Howell, A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010619225209 · Cited by 226
Original article: Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
Howell, A., Dodwell, D. J., Anderson, H., & Redford, J. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058286 · Cited by 172
Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo
Liu, H., Lee, E.-S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., Reyes, A. D. L., Wing, L., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg080 · Cited by 161
The WHI Estrogen-Alone Trial—Do Things Look Any Better?
Hulley, S. B. (2004) · JAMA · doi:10.1001/jama.291.14.1769 · Cited by 156
Weaver, D. L., Rosenberg, R. D., Barlow, W. E., Ichikawa, L., Carney, P. A., Kerlikowske, K. M., Buist, D. S. M., Geller, B. M., Key, C. R., Maygarden, S. J., et al. (2006) · Cancer · doi:10.1002/cncr.21652 · Cited by 135
Kerlikowske, K. M., Miglioretti, D. L., Ballard-Barbash, R. R., Weaver, D. L., Buist, D. S. M., Barlow, W. E., Cutter, G., Geller, B. M., Yankaskas, B. C., Taplin, S. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.151 · Cited by 129
Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening
Kuroishi, T., Tominaga, S., Morimoto, T., Tashiro, H., Itoh, S., Watanabe, H., Fukuda, M., Ota, J., Horino, T., Ishida, T., et al. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02591.x · Cited by 88
Increased patient concern after false-positive mammograms
Barton, M. B., Moore, S., Polk, S., Shtatland, E. S., Elmore, J. G., & Fletcher, S. W. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.00329.x · Cited by 87
Frequency and Predictive Value of a Mammographic Recommendation for Short-Interval Follow-Up
Yasmeen, S., Romano, P. S., Pettinger, M. B., Chlebowski, R. T., Robbins, J. A., Lane, D. S., & Hendrix, S. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.429 · Cited by 81
Self-citationThe Experience of Waiting for Diagnosis After an Abnormal Mammogram
Thorne, S. E., Harris, S. R., Hislop, T. G., & Vestrup, J. A. (1999) · The Breast Journal · doi:10.1046/j.1524-4741.1999.005001042.x · Cited by 77
Hereditary breast cancer growth rates and its impact on screening policy
Tilanus‐Linthorst, M. M. A., Kriege, M., Boetes, C., Hop, W. C. J., Obdeijn, I.-M., Oosterwijk, J. C., Peterse, H. L., Zonderland, H. M., Meijer, S., Eggermont, A. M. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.034 · Cited by 77
Estrogen as therapy for breast cancer
Ingle, J. N. (2002) · Breast Cancer Research · doi:10.1186/bcr436 · Cited by 61
Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol
Berstein, L. M., Wang, J., Zheng, H., Yue, W., Conaway, M. R., & Santen, R. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0433-03 · Cited by 57
Chen, W., Petitti, D. B., & Geiger, A. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602701 · Cited by 25
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
The endocrine management of postmenopausal women with early breast cancer
Baum, M. (2004) · Breast Cancer · doi:10.1007/bf02967995 · Cited by 1
Cited by
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Self-citationDEPARTMENT OF HEALTH & HUMAN SERVICES
Schuchat, A. (2015) · Pharmacy Today · doi:10.1016/s1042-0991(15)32122-8 · Cited by 1,098
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Metadata
- Authors
- Stefanick, M. L., Anderson, G. L., Margolis, K. L., Hendrix, S. L., Rodabough, R. J., Paskett, E. D., Lane, D. S., Hubbell, F. A., Assaf, A. R., Sarto, G. E., Schenken, R. S., Yasmeen, S., Lessin, L., Chlebowski, R. T., & WHI Investigators, F. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-04-12
- Volume
- 295
- Issue
- 14
- Pages
- 1647
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2121822533
- Cited by
- 571
- References
- 41
- FWCI
- 46.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.